Saira Imran, MBBS
Pulmonary and Critical Care Medicine
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
Internal Medicine - Memorial Hospital of Rhode Island
Pulmonary Medicine - Memorial Sloan Kettering Cancer Center; Critical Care Medicine - Memorial Sloan Kettering Cancer Center
Internal Medicine; Pulmonary Medicine
As a physician practicing in critical care, I provide care to the sickest of our cancer patients.
I developed an interest in critical care as a resident training in internal medicine. I found it challenging to provide care to some of the most vulnerable patient populations, such as people with cancer, and learned to appreciate the balance between the science of medicine and the art of healing and providing support to patients and their families. As a fellow training at Memorial Sloan Kettering, I had the privilege of caring for critically ill people. I realized the importance of the risks and benefits of treatments and procedures, which has a big impact on people with cancer.
My training at MSK included specialization in pulmonary medicine. I have a particular interest in the diagnosis and management of pulmonary complications of chemotherapy and radiation therapy, specifically for critically ill patients.
My role as a critical care provider allows me to collaborate with other specialties in the hospital. It also allows me to be available to patients and families who are facing significant hardships. We will do everything we can to get our patients through their critical illness, so they may go on to receive the cancer directed therapy they need.
We will do everything we can to get our patients through their critical illness, so they may go on to receive the cancer directed therapy they need.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Saira Imran discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.